Laurus Labs Other Announcement

Earnings Call

Laurus Labs Earnings Call Transcript: Key Takeaways

Laurus Labs delivered record revenue driven by CDMO strength and API growth. While margins improved through operating leverage, high capex continues to constrain free cash flow.

Results Update

Laurus Labs Results Update

Laurus Labs reported H1 FY27 revenue of ₹4,233 Cr and EBITDA of ₹1,406 Cr. The company acquired Galenvs Sciences and SI&C Resins to expand CDMO capabilities.

SPPS peptide synthesis capacity

16000 L

Earnings Call

Laurus Labs Investor Presentation: Key Takeaways

Q2/H1 FY27: H1 revenue ₹4,233 Cr (+31%), EBITDA ₹1,406 Cr (33.2% margin), PAT ₹809 Cr (+126%). CDMO-led growth; ₹3,000 Cr+ capex planned FY27-28.

Dividend

Laurus Labs Dividend

Laurus Labs approved a Re. 1.00 per share interim dividend for FY 2026-27. Record date is November 6, 2026; payment on or after November 19, 2026.

Management Change

Laurus Labs Management Change

Laurus Labs appointed Mr. Kundan Kumar Jha as Joint Company Secretary effective November 1, 2026, following Board approval. The KMP appointment advances the company's succession planning process.

Acquisition

Laurus Labs Acquisition Worth ₹32.5 Cr

Laurus Labs approved acquiring 52% of SI & C Resins for Rs. 32.50 Crore. The acquisition makes SI&C a subsidiary for peptide resin manufacturing.

Value

₹32.50 Cr

Other AnnouncementSTL Networks Ltd STLNETWORK

STL Networks Other Announcement

The Monitoring Agency reported Rs. 2 Crore utilization of Preferential Issue proceeds, with no deviations from objects. The report covers the quarter ending September 30, 2026.

Other AnnouncementHEG Advanced Materials Ltd HEGAM

HEG Advanced Materials Other Announcement

HEG Advanced Materials Limited has intimated the exchange regarding the change of its Corporate Identification Number (CIN) following an approved scheme of arrangement.

Other AnnouncementSanofi India Ltd SANOFI

Sanofi India Other Announcement

Sanofi India issued a communication regarding Tax Deduction at Source (TDS) for the interim dividend declared for FY 2026. Shareholders must update details by November 5, 2026.

Other AnnouncementVisaka Industries Ltd VISAKAIND

Visaka Industries Other Announcement

Visaka Industries informed the exchange about sending reminder letters to shareholders regarding the compulsory transfer of unclaimed dividends and equity shares to the IEPF account.

Other AnnouncementArvaya Healthcare Ltd BIJHANS

Arvaya Healthcare Other Announcement

Arvaya Healthcare filed its quarterly shareholding pattern under Regulation 31(1)(c). The filing reports routine ownership breakdowns with no transaction.

Other AnnouncementAYM Syntex Ltd AYMSYNTEX

AYM Syntex Other Announcement

AYM Syntex's board appointed BSR & Co. LLP as statutory auditor for five years, subject to shareholder approval. Routine auditor appointment; no monetary value involved.

Execution

Five consecutive years, from the conclusion of the 44th AGM to the conclusion of the 49th AGM